Related Experiment Video
Updated: Jun 13, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
DNA methylation-related vitamin D receptor insensitivity in breast cancer
Radharani Marik1, Maryjo Fackler, Edward Gabrielson
1Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract:
Calcitriol (1α, 25(OH)(2)-Vitamin D3) binds to the vitamin D receptor (VDR) and regulates differentiation of the normal mammary gland, and may therefore be useful in breast cancer treatment or prevention. Many breast cancer cells are, however, resistant to Calcitriol. In this study, we investigated the resistance mechanism and the role of epigenetic silencing of VDR by promoter hypermethylation. Bisulfite sequencing of the VDR promoter region revealed methylated CpG islands at -700 base pairs (bp) upstream and near the transcription start site. VDR CpG islands were demethylated by 5'deoxy-azacytidine treatment, and this was accompanied by a parallel increase in VDR mRNA levels in breast cancer cell lines. Quantitative methylation-specific PCR analyses confirmed hypermethylation of these CpG islands in primary tumors, and its absence in normal breast tissue. VDR transcripts detected in breast cancers were predominantly 5'-truncated, while normal breast tissue expressed full-length transcripts. Consistent with this observation, genes containing the VDR-responsive element (VDRE), such as cytochrome p450 hydroxylases, p21 or C/EBP were underexpressed in breast cancers compared to normal breast samples. Expression of the active longer transcripts of VDR was restored with 5'deoxy-Azacytidine (AZA) treatment, with a concurrent increase in expression of VDRE-containing genes. Thus, promoter methylation-mediated silencing of expression of the functional variants of VDR may contribute to reduced expression of downstream effectors of the VDR pathway and subsequent Calcitriol insensitivity in breast cancer. These data suggest that pharmacological reversal of VDR methylation may re-establish breast cancer cell susceptibility to differentiation therapy using Calcitriol.
Insights
Breast cancer cells resist Calcitriol due to epigenetic silencing of the vitamin D receptor (VDR) via promoter hypermethylation. Reversing this VDR methylation may restore sensitivity to Calcitriol-based differentiation therapy.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- Calcitriol (1α, 25(OH)(2)-Vitamin D3) regulates normal mammary gland differentiation via the vitamin D receptor (VDR).
- Breast cancer cells often exhibit resistance to Calcitriol, hindering its therapeutic potential.
- Epigenetic modifications, specifically promoter hypermethylation, are implicated in VDR silencing.
Purpose of the Study:
- To investigate the mechanism of Calcitriol resistance in breast cancer.
- To explore the role of VDR promoter hypermethylation in VDR silencing.
- To assess the potential of reversing VDR methylation for restoring Calcitriol sensitivity.
Main Methods:
- Bisulfite sequencing to analyze VDR promoter methylation.
- 5'deoxy-azacytidine (AZA) treatment to demethylate VDR promoter.
- Quantitative methylation-specific PCR to assess methylation in tumors and normal tissue.
- Analysis of VDR mRNA transcript length and expression of VDR-responsive genes.
Main Results:
- VDR promoter hypermethylation was identified upstream and near the transcription start site in breast cancer cells.
- AZA treatment demethylated VDR CpG islands, increasing VDR mRNA levels.
- Primary breast tumors showed hypermethylation, unlike normal breast tissue.
- Breast cancers predominantly expressed 5'-truncated VDR transcripts, while normal tissue expressed full-length VDR.
- Expression of VDR-responsive genes (e.g., p21) was reduced in breast cancers.
- AZA treatment restored full-length VDR expression and increased expression of VDRE-containing genes.
Conclusions:
- Promoter methylation-mediated silencing of functional VDR variants contributes to Calcitriol insensitivity in breast cancer.
- Reduced expression of downstream VDR pathway effectors is linked to VDR silencing.
- Pharmacological reversal of VDR methylation may re-sensitize breast cancer cells to Calcitriol differentiation therapy.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Abnormal Proliferation

